NON-INVASIVE PRENATAL TESTING (NIPT) MARKET ANALYSIS

Non-invasive Prenatal Testing (NIPT) Market, by Test Type (Panel 1 Test, Panel 2 Test, and Panel 3 Test), by Application (Trisomy, Microdeletion Syndrome, Sex chromosomes abnormalities, and Others), by End User (Hospitals, Diagnostic Laboratories, and Maternity Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Oct 2022
Code : CMI579
Pages :145
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market News

Global Non-invasive Prenatal Testing Market: Key Developments

Recommendation of new guidelines is expected to propel growth of the global non-invasive prenatal testing market over the forecast period. For instance, in August 2020, American College of Obstetricians and Gynecologists recommend new guidelines for Non-Invasive Prenatal Testing (NIPT). For example, diagnostic testing (chorionic villus sampling [CVS] or amniocentesis) options should be discussed and offered to all pregnant patients regardless of maternal age or risk of chromosomal abnormality, all patients should be offered a second-trimester ultrasound for fetal structural defects, etc.

Major players in the global non-invasive prenatal testing market are focused on raising funds to enhance their market share. For instance, in March 2020, BillionToOne, Inc. raised US$ 15 million to support the commercial expansion of UNITY, a prenatal screen that directly assesses the baby’s risk for common and severe inherited disorders such as cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to all the U.S.